Biodesix Targeting Pharma for VeriStrat Adoption, Growth

While the company continues clinical studies showing the utility of its proteomics-based VeriStrat test in predicting response to cancer therapies, it also is forging partnerships with pharma for use of the test.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.